Amgen Inc. (AMGN): Price and Financial Metrics


Amgen Inc. (AMGN): $283.29

-1.62 (-0.57%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AMGN to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

AMGN POWR Grades

  • Quality is the dimension where AMGN ranks best; there it ranks ahead of 99.26% of US stocks.
  • AMGN's strongest trending metric is Growth; it's been moving down over the last 177 days.
  • AMGN's current lowest rank is in the Momentum metric (where it is better than 12.41% of US stocks).

AMGN Stock Summary

  • With a market capitalization of $152,022,051,581, AMGEN INC has a greater market value than 98.8% of US stocks.
  • AMGEN INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 94.75% of US listed stocks.
  • AMGN's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 97.55% of US stocks.
  • If you're looking for stocks that are quantitatively similar to AMGEN INC, a group of peers worth examining would be TXN, RTX, BMY, GILD, and DE.
  • Visit AMGN's SEC page to see the company's official filings. To visit the company's web site, go to www.amgen.com.

AMGN Valuation Summary

  • AMGN's price/earnings ratio is 22.3; this is 4.7% lower than that of the median Healthcare stock.
  • Over the past 243 months, AMGN's EV/EBIT ratio has gone up 78.8.

Below are key valuation metrics over time for AMGN.

Stock Date P/S P/B P/E EV/EBIT
AMGN 2022-12-01 5.8 41.8 22.3 20.1
AMGN 2022-11-30 5.8 41.8 22.4 20.1
AMGN 2022-11-29 5.7 41.2 22.0 19.8
AMGN 2022-11-28 5.7 41.3 22.1 19.9
AMGN 2022-11-25 5.8 41.4 22.2 19.9
AMGN 2022-11-23 5.7 41.4 22.1 19.9

AMGN Growth Metrics

    The year over year cash and equivalents growth rate now stands at 6.81%.
  • Its 3 year cash and equivalents growth rate is now at -11.28%.
  • Its 5 year cash and equivalents growth rate is now at 137.18%.
AMGN's revenue has moved up $3,339,000,000 over the prior 70 months.

The table below shows AMGN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 26,330 9,880 6,835
2022-06-30 26,384 9,320 6,576
2022-03-31 26,316 9,321 5,723
2021-12-31 25,979 9,261 5,893
2021-09-30 25,767 8,606 5,609
2021-06-30 25,484 9,556 5,746

AMGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AMGN has a Quality Grade of A, ranking ahead of 98.04% of graded US stocks.
  • AMGN's asset turnover comes in at 0.412 -- ranking 113th of 682 Pharmaceutical Products stocks.
  • UTHR, NBY, and AERI are the stocks whose asset turnover ratios are most correlated with AMGN.

The table below shows AMGN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.412 0.754 0.169
2021-06-30 0.408 0.753 0.169
2021-03-31 0.395 0.756 0.196
2020-12-31 0.400 0.758 0.206
2020-09-30 0.398 0.767 0.220
2020-06-30 0.395 0.782 0.225

AMGN Price Target

For more insight on analysts targets of AMGN, see our AMGN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $250.00 Average Broker Recommendation 1.78 (Moderate Buy)

AMGN Stock Price Chart Interactive Chart >

Price chart for AMGN

AMGN Price/Volume Stats

Current price $283.29 52-week high $296.67
Prev. close $284.91 52-week low $207.36
Day low $281.69 Volume 2,479,300
Day high $287.44 Avg. volume 3,002,708
50-day MA $264.37 Dividend yield 2.72%
200-day MA $247.58 Market Cap 151.16B

Amgen Inc. (AMGN) Company Bio


Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980. Amgen's Thousand Oaks staff in 2017 numbered 5,125 (7.5% of total city employment) and included hundreds of scientists, making Amgen the largest employer in Ventura County. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology. (Source:Wikipedia)  


AMGN Latest News Stream


Event/Time News Detail
Loading, please wait...

AMGN Latest Social Stream


Loading social stream, please wait...

View Full AMGN Social Stream

Latest AMGN News From Around the Web

Below are the latest news stories about AMGEN INC that investors may wish to consider to help them evaluate AMGN as an investment opportunity.

7 Christmas Stocks to Buy for Happy Holidays

2022 took a toll on a lot of portfolios, leaving many investors feeling more like a Grinch than looking for Christmas stocks to buy.

Louis Navellier and the InvestorPlace Research Staff on InvestorPlace | December 5, 2022

Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi

Johnson & Johnson dropped out of the bidding process for Horizon Therapeutics, pushing HZNP stock into the red on Monday.

Yahoo | December 5, 2022

Amgen says experimental obesity drug has promising durability

Amgen Inc's experimental obesity drug demonstrated promising durability trends in an early trial, paving the way for a larger mid-stage study early next year, company officials said ahead of a data presentation on Saturday. The small Phase I trial found that patients maintained their weight loss for 70 days after receiving the highest tested dose of the injected drug, currently known as AMG133. Amgen shares have gained about 5% since the company said on Nov. 7 that 12 weeks of trial treatment at the highest monthly dose of AMG133 resulted in mean weight loss of 14.5%.

Yahoo | December 3, 2022

Amgen (NASDAQ:AMGN) shareholders have earned a 14% CAGR over the last five years

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

Yahoo | December 2, 2022

Is Amgen Stock a Buy for Income Investors?

Economic and geopolitical concerns have weighed heavily on investor sentiment throughout the year. Investors seeking more certainty in an uncertain environment would do well to consider buying safe, high-yielding dividend stocks. This is because the highest-quality income stocks can provide ever-growing passive income to investors through almost any economic downturn.

Yahoo | December 2, 2022

Read More 'AMGN' Stories Here

AMGN Price Returns

1-mo 2.97%
3-mo 16.21%
6-mo 19.76%
1-year 38.29%
3-year 32.44%
5-year 87.22%
YTD 29.90%
2021 0.87%
2020 -1.99%
2019 27.60%
2018 15.23%
2017 22.27%

AMGN Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full AMGN Dividend History

Continue Researching AMGN

Want to see what other sources are saying about Amgen Inc's financials and stock price? Try the links below:

Amgen Inc (AMGN) Stock Price | Nasdaq
Amgen Inc (AMGN) Stock Quote, History and News - Yahoo Finance
Amgen Inc (AMGN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8813 seconds.